-
Verity Pharma and India’s SII apply to distribute AstraZeneca vaccine in Canada
expresspharma
February 03, 2021
Verity Pharmaceuticals and Serum Institute of India (SII) have applied to distribute SII’s licensed version of AstraZeneca’s COVID-19 vaccine in Canada, potentially easing shortages as European manufacturing sites struggle to meet global demand.
-
Caplin Steriles, JAMP Pharma Group sign agreement for six injectable products in Canada
expresspharma
January 19, 2021
Caplin Point Laboratories announced that its subsidiary, Caplin Steriles has entered into a strategic partnership with JAMP Pharma Group for six injectable products to be filed shortly in Canada. Some of these products have already been filed by ...
-
Canada to invest up to C$214 mn for R&D of home grown COVID-19 vaccines: Trudeau
expresspharma
October 26, 2020
Canada will invest up to C$214 million ($162.8 million) to help develop a domestically made COVID-19 vaccine, and it has secured up to 76 million doses of Quebec City-based Medicago’s potential vaccine, Prime Minister Justin Trudeau said on Friday.
-
COVID-19 vaccine doses could arrive in Canada early in 2021: minister
Yahoo!Finance
September 24, 2020
Canada's minister of procurement said the country is "aggressively negotiating" with drugmakers on delivery schedules for potential COVID-19 vaccines, adding that shipments would begin early in 2021 under existing deals, as reported in Yahoo!Finance.
-
FDA takes first action under new international collaboration with Australia and Canada
worldpharmanews
September 18, 2019
The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE).
-
Canada announces changes to lower medicine prices
pharmaceutical-technology
August 13, 2019
The Government of Canada has made changes to its Patented Medicines Regulations, initially introduced in 1987, in a bid to lower prices of prescription medicines.
-
Trump Admin Announces Plan to Allow Drug Imports From Canada
drugs
August 02, 2019
Americans could import less expensive prescription drugs from Canada under a plan being developed by the Trump administration.
-
Inhibrx Announces Agreement for INBRX-101 outside US, Canada with Chiesi Group
americanpharmaceuticalreview
May 31, 2019
Inhibrx has entered into an agreement with Chiesi Farmaceutici. The agreement grants Chiesi Group an option to exclusively license, develop and commercialize INBRX-101 outside of ...
-
British Columbia in Canada switches patients to biosimilars
pharmaceutical-technology
May 30, 2019
British Columbia (BC) has revealed plans to switch certain patients under public drug programme PharmaCare from biologics to biosimilars.
-
Health Canada issues Notice of Compliance with Conditions (NOC/c) for Libtayo (cemiplimab), the first and only biologic for the treatment of advanced cutaneous squamous cell carcinoma (CSCC)
firstwordpharma
April 12, 2019
CSCC is the second most common skin cancer in Canadai.